ELYM NASDAQ
Eliem Therapeutics, Inc.
1W: -14.4%
1M: -17.5%
3M: -49.5%
1Y: +55.7%
3Y: -77.7%
$5.11
Last traded 2024-10-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-58M
Net Income
-23.2% YoY
$-53M
Free Cash Flow
-14.5% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-27.1%
ROA-26.3%
ROIC-88.6%
Valuation
P/E-6.2
P/B1.6
EV/EBITDA-27.7
Leverage
Debt/Equity0.01
Current Ratio31.45
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z26.85
Beneish M0.00